Invention Grant
- Patent Title: Anti-DLL3 antibody drug conjugates and methods of use
-
Application No.: US14466945Application Date: 2014-08-22
-
Publication No.: US09011854B2Publication Date: 2015-04-21
- Inventor: Robert A Stull , Laura Saunders , Scott J. Dylla , Orit Foord , David Liu , Michael Torgov , Hui Shao
- Applicant: Stem Centrx, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Stemcentrx, Inc.
- Current Assignee: Stemcentrx, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Womble Carlyle Sandridge & Rice, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/28 ; A61K47/48 ; C07K16/30 ; A61K31/5517 ; G01N33/574 ; C07K16/18 ; A61K39/00
Abstract:
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Public/Granted literature
- US09089616B2 Anti-DLL3 antibody drug conjugates and methods of use Public/Granted day:2015-07-28
Information query
